Kura Oncology has appointed John Farnam to the newly created position of chief operating officer, effective July 1, 2018. In addition, Bridget Martell, M.A., M.D., and Blake Tomkinson, Ph.D., MBA, have joined the company as vice presidents of Clinical Development. “This expansion of our leadership team comes at a key inflection point for Kura as we prepare for our first registration-directed trial,” said Troy Wilson, Ph.D., J.D., president and chief executive officer of Kura Oncology. “Jo...